Sector Chart Amicogen, Inc.

Stocks

A092040

KR7092040005

Biotechnology & Medical Research

End-of-day quote Korea S.E. 01/09/2026			5-day change	1st Jan Change
1,011.00 ^KRW	+5.53%		+2.02%	-43.27%

08-04	Amicogen, Inc. cancelled the transaction announced on June 22, 2026	CI
06-22	Amicogen, Inc. announced that it expects to receive KRW 9.9999989 billion in funding	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes